Status:
UNKNOWN
EXPRE-SON-REA : Expressive Own Names in Neurophysiologic Assessment of Comatose Patients
Lead Sponsor:
Centre Hospitalier St Anne
Conditions:
Comatose
Neurophysiologic Abnormality
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Evaluating the neurologic prognosis in disorders of consciousness (DOC) patients is still a crucial issue in intensive care units. Neurophysiology allows the investigators to record cerebral response...
Detailed Description
Late auditory evoked potentials (as P3 wave) are used in neurophysiology to assess the level of consciousness in DOC (disorder of consciousness) patients. The P3 wave, elicited by listening standard a...
Eligibility Criteria
Inclusion
- Age over 18
- Disorder of consciousness defined as :
- Glasgow coma scale \< 8 or \>8 but
- eyes opening to pain only
- No response to basic command
- Available neuro-imagery (CT-scan or MRI)
- Normal temperature (no fever or hypothermia)
- Normal blood pressure during neurophysiologic evaluation
- Given consent from relatives
Exclusion
- Brain death
- Known deafness
- Severe sepsis uncontrolled during neurophysiologic evaluation
Key Trial Info
Start Date :
July 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2022
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT04798508
Start Date
July 30 2020
End Date
October 30 2022
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GHU Paris Psychiatrie Neurosciences
Paris, France, 75014